DK0839033T3 - Anvendelse af L-carnitin og derivater til reducering af ceramidniveauer og potensering af antiretroviral virkning - Google Patents

Anvendelse af L-carnitin og derivater til reducering af ceramidniveauer og potensering af antiretroviral virkning

Info

Publication number
DK0839033T3
DK0839033T3 DK96924124T DK96924124T DK0839033T3 DK 0839033 T3 DK0839033 T3 DK 0839033T3 DK 96924124 T DK96924124 T DK 96924124T DK 96924124 T DK96924124 T DK 96924124T DK 0839033 T3 DK0839033 T3 DK 0839033T3
Authority
DK
Denmark
Prior art keywords
potentiate
carnitine
derivatives
ceramide levels
antiretroviral action
Prior art date
Application number
DK96924124T
Other languages
Danish (da)
English (en)
Inventor
Sonia Moretti
Original Assignee
Sigma Tau Ind Farmaceuti
Mendes Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Mendes Srl filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK0839033T3 publication Critical patent/DK0839033T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96924124T 1995-08-03 1996-07-19 Anvendelse af L-carnitin og derivater til reducering af ceramidniveauer og potensering af antiretroviral virkning DK0839033T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95RM000544A IT1277897B1 (it) 1995-08-03 1995-08-03 Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
PCT/IT1996/000146 WO1997005864A2 (en) 1995-08-03 1996-07-19 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs

Publications (1)

Publication Number Publication Date
DK0839033T3 true DK0839033T3 (da) 2004-06-21

Family

ID=11403512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96924124T DK0839033T3 (da) 1995-08-03 1996-07-19 Anvendelse af L-carnitin og derivater til reducering af ceramidniveauer og potensering af antiretroviral virkning

Country Status (18)

Country Link
US (2) US6040346A (de)
EP (1) EP0839033B1 (de)
JP (1) JPH11510181A (de)
KR (1) KR100412532B1 (de)
CN (1) CN1161116C (de)
AR (1) AR004503A1 (de)
AT (1) ATE260654T1 (de)
AU (1) AU719906B2 (de)
BR (1) BR9609947A (de)
CA (1) CA2228266C (de)
DE (1) DE69631768T2 (de)
DK (1) DK0839033T3 (de)
ES (1) ES2216050T3 (de)
IT (1) IT1277897B1 (de)
PT (1) PT839033E (de)
RU (2) RU2203047C2 (de)
TW (1) TW464493B (de)
WO (1) WO1997005864A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
IT1277898B1 (it) 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
US20010025027A1 (en) * 2000-03-07 2001-09-27 Sonis Stephen T. Inhibition of ceramide for the prevention and treatment of oral mucositis induced by antineoplastic drugs or radiation
IT1317938B1 (it) * 2000-11-17 2003-07-15 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di alterazioni delmetabolismo lipidico, delle forme allergiche e per attivare le difese
EP2586438A1 (de) * 2011-10-28 2013-05-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Verbindung zur Verwendung bei der Vorbeugung von kognitiven Mangelerscheinungen bei einem Neugeborenen von einer HIV-serumpositiven Mutter, die mit Azidothymidin
RU2559179C1 (ru) * 2014-03-24 2015-08-10 Илья Александрович Марков Фармацевтическая композиция для лечения тяжелых форм вирусных инфекций в виде таблеток
DE202017102551U1 (de) 2017-04-28 2017-06-01 E-Lead Electronic Co., Ltd. Verstellbares Allzeit-Head-Up-Displaysystem
EP4125858B1 (de) * 2020-04-28 2026-05-06 Lonza Greenwood LLC Nährstoffzusammensetzung enthaltend l-carnitintartrat zur verwendung bei der behandlung oder prävention einer coronavirusinfektion bei einem säuger

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IE903343A1 (en) * 1989-09-18 1991-04-10 Smithkline Beecham Corp FORMULATION FOR SOLUBLE sT4 FOR TREATMENT OF HIV INFECTION
ATE192037T1 (de) * 1989-12-29 2000-05-15 Braun Medical Inc Verwendung von arginin als immunstimulator
IT1255039B (it) * 1992-03-11 1995-10-13 Sigma Tau Ind Farmaceuti Impiego di l-carnitina nel trattamento di pazienti hiv-sieropositivi presentanti deficit di carnitina.
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di

Also Published As

Publication number Publication date
PT839033E (pt) 2004-07-30
EP0839033A2 (de) 1998-05-06
IT1277897B1 (it) 1997-11-12
WO1997005864A2 (en) 1997-02-20
AR004503A1 (es) 1998-12-16
US6040346A (en) 2000-03-21
JPH11510181A (ja) 1999-09-07
AU6469096A (en) 1997-03-05
ES2216050T3 (es) 2004-10-16
ITRM950544A0 (it) 1995-08-03
HK1015273A1 (en) 1999-10-15
DE69631768T2 (de) 2005-01-13
TW464493B (en) 2001-11-21
ITRM950544A1 (it) 1997-02-03
DE69631768D1 (de) 2004-04-08
CA2228266A1 (en) 1997-02-20
EP0839033B1 (de) 2004-03-03
CA2228266C (en) 2009-05-12
CN1161116C (zh) 2004-08-11
RU2269340C2 (ru) 2006-02-10
MX9800915A (es) 1998-10-31
BR9609947A (pt) 1999-02-02
KR100412532B1 (ko) 2004-06-10
CN1193912A (zh) 1998-09-23
RU2203047C2 (ru) 2003-04-27
WO1997005864A3 (en) 1997-04-17
KR19990036149A (ko) 1999-05-25
AU719906B2 (en) 2000-05-18
US20040039054A1 (en) 2004-02-26
ATE260654T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
DK108997A (da) Fremstilling og krystalformer af 2-methylthien-benzodiazepin
DK0844875T3 (da) Anvendelse af L-carnitin og acylderivater til nedsættelse af ceramidniveauer
LV11895A (lv) 4-benzoilpirazola atvasinajumi un to pielietojums par herbicidiem
HUP9801577A3 (en) Synergistic herbicidal composition of s-metolachlor and its use
NO975331D0 (no) Anvendelse av R-enantiomer av N-propargyl-1-aminoindan salter og sammensetninger derav
KR960032380U (ko) 컴퓨터 케이스의 체결장치
DK0966436T3 (da) Arylsulfonamider og analoger deraf og anvendelse deraf til behandling af neurodegenerative lidelser
DK1167364T3 (da) Benzopyranholdige forbindelser og promedikamentformer af disse
PT1123255E (pt) Coluna de bolhas e sua utilizacao
KR970020774U (ko) 몸을 돌려 감아서 고정시키기에 용이한 수건
DK0817637T3 (da) Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC
BR9710109A (pt) Composições de massa usadas para preparar petiscos de reduzida e baixa caloria
LV12259A (lv) Jauna r-alfa-propilpiperonilamina un ta analogu asimetriska sinteze
NO963723L (no) Flytepunktnedsettende tilsetningsstoffer og deres anvendelse
BR9609947A (pt) Uso de l-carnitina e derivados para reduzir níveis de ceramida e potencializa anti-retroviral
FR2757059B1 (fr) Nouvelle application therapeutique des derives du pyrrole
NO952599D0 (no) Stoppeklokke og klokkesystem
FR2731531B1 (fr) Montre notamment du type montre-bracelet
KR900006878A (ko) 파면 벡터 상관 인자 프로세서 및 이의 상관방법
IT1271733B (it) Guaina flessibile in pvf3 e sua applicazione ai flessibili metallici
KR970020477U (ko) 마늘 껍질 제거기의 구조
KR970006854U (ko) 시계 바늘의 결합구조
DK0840609T3 (da) Anvendelse af usubstituerede og substituerede N-(pyrrol-1-yl)pyridinaminer som antikonvulsive midler
KR970019262U (ko) 사용경과시간을 알리는 컴퓨터
KR970006851U (ko) 12지신을 이용한 시계의 문자판